Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy.
Baril
L
L
Département de Maladies Infectieuses et de Médecine Tropicale, H pital de la Pitié-Salpêtrière, Paris, France.
Beucler
I
I
Valantin
M A
MA
Bruckert
E
E
Bonnefont-Rousselot
D
D
Coutellier
A
A
Caumes
E
E
Katlama
C
C
Bricaire
F
F
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D053304:Apolipoprotein C-II; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C / Q000097:blood; D002784:Cholesterol / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D006493:Heparin; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced* / Q000201:enzymology; D008049:Lipase / Q000097:blood*; D008071:Lipoprotein Lipase / Q000097:blood*; D008297:Male; D014280:Triglycerides / Q000097:blood
D053304:Apolipoprotein C-II; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C; D005230:Fatty Acids, Nonesterified; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol; D008049:Lipase; D008071:Lipoprotein Lipase